Skip to main content
. 2016 Mar 3;7(20):28935–28946. doi: 10.18632/oncotarget.7898

Figure 2. The effects of CB on in vivo tumor growth in human NSCLC cell lines and in vitro cell growth in rat splenocytes.

Figure 2

A. tumor volume and B. body weight over time in response to treatment with CB or platinum drugs in A549 NSG xenograft mouse models (n = 10 mice/each group). Error bars are SD. Down arrows indicate time point from each treatment with vehicle, CB or platinum drugs. All * p < 0.0001 vs. vehicle, Fisher's PLSD test. All experiments were repeated two times. C and D. rat splenocytes were treated for 24 hours with CB and platinum drugs, respectively. Representative images of the splenocytes with different concentrations of CB. Quantitative cell viabilities (%) are presented as mean ± SD of triplicates. All p > 0.05, one-way ANOVA followed by LSD test. All experiments were repeated three times.